-
公开(公告)号:US20230332154A1
公开(公告)日:2023-10-19
申请号:US18330853
申请日:2023-06-07
申请人: Bioneer Corporation
发明人: Tae-Rim KIM , Pyoung Oh YOON , Youngho KO , Seon Joo BAE , Han-Oh PARK , Seung Seob SON , Jun-Hong PARK , Sung-Il YUN
IPC分类号: C12N15/113 , A61P11/00 , A61K9/19 , A61K31/713
CPC分类号: C12N15/1136 , A61P11/00 , A61K9/19 , A61K31/713 , C12N2310/14 , C12N2310/314 , C12N2310/322 , C12N2310/351 , C12N2310/3515
摘要: The present invention relates to a double-stranded oligonucleotide which can highly specifically and efficiently inhibit an amphiregulin expression and, preferably, a double-stranded oligonucleotide comprising a sequence in the form of RNA/RNA, DNA/DNA or DNA/RNA hybrid, a double-stranded oligonucleotide structure comprising the double-stranded oligonucleotide, nanoparticles comprising the double-stranded oligonucleotide structure, and a fibrosis or respiratory disease preventive or therapeutic use thereof.
-
公开(公告)号:US20220088051A1
公开(公告)日:2022-03-24
申请号:US17423372
申请日:2020-01-15
申请人: BIONEER CORPORATION
发明人: Han-Oh PARK , Sung II YUN , Sang-Jin BYUN , Pyoung Oh YOON , Sang-Kyu LEE , Tae-Rim KIM , Young-Ho KO , Seung-Seob SON , Eun-Ah GOH , Hyung-Jin KIM
IPC分类号: A61K31/713 , A61P17/14
摘要: The present invention pertains to: a double-stranded oligonucleotide construct having a structure in which a hydrophilic substance and a hydrophobic substance are conjugated by a simple covalent bond or a linker-mediated covalent bond at both ends of a DKK1-specific double-stranded oligonucleotide to efficiently deliver the double-stranded oligonucleotide into cells; a nanoparticle capable of being produced through self-assembly of the double-stranded oligonucleotide construct through a hydrophobic interaction in an aqueous solution; and a hair-loss-preventing and hair-growth-promoting composition containing the double-stranded oligonucleotide construct or the nanoparticle. A double-stranded oligonucleotide construct including a DKK1-specific double-stranded oligonucleotide, a nanoparticle, and a hair loss prevention or hair growth composition containing the double-stranded oligonucleotide construct or the nanoparticle as an active ingredient according to the present invention very efficiently suppress the expression of DKK1 without side effects and are remarkably effective for preventing hair loss and promoting hair growth, and can thus be very usefully used for a composition for preventing hair loss and promoting hair growth.
-
公开(公告)号:US20170130231A1
公开(公告)日:2017-05-11
申请号:US15301713
申请日:2015-04-06
申请人: Bioneer Corporation
发明人: Jeiwook CHAE , Pyoung Oh YOON , Boram HAN , Mi Na KIM , Youngho KO , Han Oh PARK
IPC分类号: C12N15/113
CPC分类号: C12N15/1136 , C12N15/113 , C12N2310/14 , C12N2310/351 , C12N2310/3515 , C12N2320/32
摘要: The present invention relates to a novel siRNA, and a high-efficiency double-stranded oligo RNA structure containing the same, and a nanoparticle containing the high-efficiency double-stranded oligo RNA structure. The double-stranded oligo RNA structure has a structure in which a hydrophilic material and a hydrophobic material are conjugated to both ends of a double-stranded oligo RNA (siRNA) via a simple covalent bond or linker-mediated covalent bond in order to be efficiently delivered into cells, and may be converted into a nanoparticle form in an aqueous solution by hydrophobic interactions of double-stranded oligo RNA structures. It is preferable that the siRNA contained in the double-stranded oligo RNA structure is an siRNA specific for fibrosis or respiratory disease-related gene, particularly, amphiregulin or stratifin.In addition, the present invention relates to a pharmaceutical composition for preventing or treating fibrosis or respiratory diseases, containing an siRNA, a high-efficiency double-stranded oligo RNA structure containing the siRNA, or a nanoparticle containing the high-efficiency double-stranded oligo RNA structure, as an active ingredient.In addition, the present invention relates to a method of preventing or treating fibrosis or respiratory diseases, including administering the pharmaceutical composition for preventing or treating fibrosis or respiratory diseases to a subject in need thereof.
-
公开(公告)号:US20230203494A1
公开(公告)日:2023-06-29
申请号:US18067363
申请日:2022-12-16
申请人: BIONEER CORPORATION
发明人: Tae-Rim KIM , Pyoung Oh YOON , Youngho KO , Seon Joo BAE , Han-Oh PARK , Seung Seob SON , Jun-Hong PARK , Sung-II YUN
IPC分类号: C12N15/113 , A61P11/00 , A61K9/19 , A61K31/713
CPC分类号: C12N15/1136 , A61P11/00 , A61K9/19 , A61K31/713 , C12N2310/14 , C12N2310/314 , C12N2310/322 , C12N2310/351 , C12N2310/3515
摘要: The present invention relates to a double-stranded oligonucleotide which can highly specifically and efficiently inhibit an amphiregulin expression and, preferably, a double-stranded oligonucleotide comprising a sequence in the form of RNA/RNA, DNA/DNA or DNA/RNA hybrid, a double-stranded oligonucleotide structure comprising the double-stranded oligonucleotide, nanoparticles comprising the double-stranded oligonucleotide structure, and a fibrosis or respiratory disease preventive or therapeutic use thereof.
-
公开(公告)号:US20210189398A1
公开(公告)日:2021-06-24
申请号:US17057852
申请日:2019-05-22
申请人: BIONEER CORPORATION
发明人: Tae-Rim KIM , Pyoung Oh YOON , Youngho KO , Seon Joo BAE , Han-Oh PARK , Seung Seob SON , Jun-Hong PARK , Sung-II YUN
IPC分类号: C12N15/113 , A61K9/19 , A61P11/00
摘要: The present invention relates to a double-stranded oligonucleotide which can highly specifically and efficiently inhibit an amphiregulin expression and, preferably, a double-stranded oligonucleotide comprising a sequence in the form of RNA/RNA, DNA/DNA or DNA/RNA hybrid, a double-stranded oligonucleotide structure comprising the double-stranded oligonucleotide, nanoparticles comprising the double-stranded oligonucleotide structure, and a fibrosis or respiratory disease preventive or therapeutic use thereof.
-
-
-
-